利润表（君实生物）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 1,271,200,009.95 | 786,056,275.43 | 380,804,271.07 | 1,502,549,915.75 | 986,457,567.67 | 669,702,667.07 | 255,154,522.24 |
| 营业收入(元) | 1,271,200,009.95 | 786,056,275.43 | 380,804,271.07 | 1,502,549,915.75 | 986,457,567.67 | 669,702,667.07 | 255,154,522.24 |
| 二、营业总成本(元) | 2,261,152,311.32 | 1,434,750,281.60 | 703,379,531.60 | 3,811,859,509.40 | 2,479,371,840.85 | 1,772,814,913.95 | 897,619,704.33 |
| 营业成本(元) | 325,339,075.87 | 210,419,748.58 | 108,094,203.03 | 540,976,390.72 | 336,845,004.30 | 252,155,636.11 | 85,512,504.23 |
| 研发费用(元) | 874,268,925.53 | 546,376,150.47 | 276,292,124.92 | 1,937,469,544.84 | 1,270,626,649.07 | 948,598,826.58 | 527,659,904.54 |
| 营业税金及附加(元) | 17,132,866.24 | 11,611,663.96 | 5,643,377.09 | 19,704,320.97 | 13,435,038.40 | 8,775,955.55 | 3,580,874.72 |
| 销售费用(元) | 683,629,829.87 | 427,553,592.62 | 191,592,867.84 | 844,355,927.00 | 554,408,514.86 | 373,126,850.39 | 182,621,658.30 |
| 管理费用(元) | 353,242,444.41 | 239,719,730.60 | 123,309,563.52 | 536,439,566.54 | 359,400,187.23 | 232,304,096.15 | 113,138,405.85 |
| 财务费用(元) | 7,539,169.40 | -930,604.63 | -1,552,604.80 | -67,086,240.67 | -55,343,553.01 | -42,146,450.83 | -14,893,643.31 |
| 其中：利息费用(元) | 32,912,225.93 | 20,686,103.23 | 11,684,234.17 | 23,006,975.29 | 19,975,951.59 | 12,720,671.54 | 8,401,000.33 |
| 其中：利息收入(元) | 32,647,344.93 | 24,453,746.85 | 13,959,616.53 | 99,426,230.82 | 77,612,046.32 | 55,026,734.29 | 28,390,869.19 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | -30,053,190.85 | -32,147,749.55 | -1,154,733.64 | -149,177,392.25 | -45,848,211.85 | -27,766,182.96 | -6,124,837.69 |
| 加：投资收益(元) | -17,147,524.18 | -27,835,848.07 | -7,397,349.03 | 73,990,355.55 | -44,866,462.66 | -28,070,638.56 | -13,859,165.98 |
| 其中：对联营企业和合营企业的投资收益(元) | -24,444,582.77 | -28,224,879.11 | -7,335,159.69 | -60,484,681.25 | -49,100,983.21 | -32,305,159.11 | -15,625,741.32 |
| 资产处置收益(元) | 12,891,972.67 | 12,938,477.30 | 23,722,664.29 | 29,406,432.28 | 600,424.64 | 510,895.52 | - |
| 资产减值损失(元) | -3,641,769.04 | -381,606.68 | 6,318,900.98 | -126,313,501.28 | -35,245,743.13 | -36,357,648.87 | -19,041,224.70 |
| 信用减值损失(元) | 11,174,765.63 | 10,415,866.31 | 2,695,299.66 | -23,483,189.23 | -1,113,612.12 | -1,122,091.90 | -1,474,515.08 |
| 其他收益(元) | 47,607,041.87 | 10,019,476.80 | 5,554,844.40 | 47,444,534.82 | 39,025,160.64 | 33,625,928.15 | 49,746,629.66 |
| 四、营业利润(元) | -969,121,005.27 | -675,685,390.06 | -292,835,633.87 | -2,457,442,353.76 | -1,580,362,717.66 | -1,162,291,985.50 | -633,218,295.88 |
| 加：营业外收入(元) | 877,766.70 | 818,405.29 | 17,162.50 | 3,913,286.20 | 3,928,909.10 | 3,611,791.11 | 4,500.88 |
| 减：营业外支出(元) | 16,400,811.52 | 9,290,891.21 | 3,730,898.82 | 38,165,533.03 | 31,081,561.88 | 18,144,094.93 | 4,240,073.76 |
| 五、利润总额(元) | -984,644,050.09 | -684,157,875.98 | -296,549,370.19 | -2,491,694,600.59 | -1,607,515,370.44 | -1,176,824,289.32 | -637,453,868.76 |
| 减：所得税费用(元) | 4,081,640.85 | 3,551,165.51 | 3,098,595.27 | 43,994,697.26 | -52,386,479.09 | -50,494,762.83 | 2,166,076.03 |
| 六、净利润(元) | -988,725,690.94 | -687,709,041.49 | -299,647,965.46 | -2,535,689,297.85 | -1,555,128,891.35 | -1,126,329,526.49 | -639,619,944.79 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | -988,725,690.94 | -687,709,041.49 | -299,647,965.46 | -2,535,689,297.85 | -1,555,128,891.35 | -1,126,329,526.49 | -639,619,944.79 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | -926,768,557.18 | -644,954,683.24 | -283,029,082.76 | -2,283,431,860.25 | -1,406,818,402.73 | -997,412,406.48 | -543,432,303.73 |
| 少数股东损益(元) | -61,957,133.76 | -42,754,358.25 | -16,618,882.70 | -252,257,437.60 | -148,310,488.62 | -128,917,120.01 | -96,187,641.06 |
| 扣除非经常性损益后的净利润(元) | -939,839,865.37 | -627,230,959.64 | -307,067,930.26 | -2,297,558,800.00 | -1,359,414,840.05 | -971,394,283.52 | -559,429,097.59 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | -0.94 | -0.65 | -0.29 | -2.32 | -1.43 | -1.01 | -0.55 |
| 二、稀释每股收益(元) | -0.94 | -0.65 | -0.29 | -2.32 | -1.43 | -1.01 | -0.55 |
| 八、其他综合收益(元) | -47,944,698.90 | -24,342,498.84 | 852,568.88 | -73,658,461.53 | -50,732,766.43 | -38,178,177.32 | -27,447,285.04 |
| 归属于母公司股东的其他综合收益(元) | -47,944,698.90 | -24,342,498.84 | 852,568.88 | -73,658,461.53 | -50,732,766.43 | -38,178,177.32 | -27,447,285.04 |
| 九、综合收益总额(元) | -1,036,670,389.84 | -712,051,540.33 | -298,795,396.58 | -2,609,347,759.38 | -1,605,861,657.78 | -1,164,507,703.81 | -667,067,229.83 |
| 归属于母公司所有者的综合收益总额(元) | -974,713,256.08 | -669,297,182.08 | -282,176,513.88 | -2,357,090,321.78 | -1,457,551,169.16 | -1,035,590,583.80 | -570,879,588.77 |
| 归属于少数股东的综合收益总额(元) | -61,957,133.76 | -42,754,358.25 | -16,618,882.70 | -252,257,437.60 | -148,310,488.62 | -128,917,120.01 | -96,187,641.06 |
| 公告日期 | 2024-10-30 | 2024-08-31 | 2024-04-30 | 2024-03-29 | 2023-10-28 | 2023-08-31 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries